Variable | LBW | OR (95% CI) | p-value | AOR (95% CI) | p-value | |
---|---|---|---|---|---|---|
No n (%) | Yes n (%) | |||||
Age groups | ||||||
 18–24 | 254 (92.0) | 22 (8.0) | 0.8 (0.30–2.0) | 0.60 | 0.25 (0.06–1.04) | 0.06 |
 25–29 | 171 (95.5) | 8 (4.5) | 0.4 (0.14–1.28) | 0.13 | 0.20 (0.05–0.84) | 0.03 |
 30–34 | 110 (95.7) | 5 (4.3) | 0.4 (0.12–1.39) | 0.15 | 0.32 (0.09–1.19) | 0.09 |
  ≥ 35 | 55 (90.2) | 6 (9.8) | 1 |  |  |  |
Marital status | ||||||
 Unmarried | 148 (94.3) | 9 (5.7) | 1.2 (0.56–2.55) | 0.65 |  |  |
 Married | 442 (93.2) | 32 (6.8) |  |  |  |  |
Education level | ||||||
 No formal education | 24 (96.0) | 1 (4.0) | 0.8 (0.04–12.82) | 0.84 |  |  |
 Primary education | 342 (93.4) | 24 (6.6) | 1.3 (0.16–9.87) | 0.82 |  |  |
 Secondary education | 206 (93.2) | 15 (6.8) | 1.3 (0.16–10.50) | 0.80 |  |  |
 Tertiary education | 18 (94.7) | 1 (5.3) | 1 |  |  |  |
Attendance to ANC | ||||||
  < 4 | 206 (91.2) | 20 (8.8) | 1.7 (0.88–3.14) | 0.12 | 1.33 (0.62–2.89) | 0.46 |
  ≥ 4 | 384 (94.8) | 21 (5.2) | 1 |  |  |  |
FEFO use | ||||||
 No | 17 (94.4) | 1 (5.6) | 0.8 (0.11–6.49) | 0.87 |  |  |
 Yes | 573 (93.5) | 40 (6.5) | 1 |  |  |  |
Mebendazole use | ||||||
 No | 34 (97.1) | 1 (2.9) | 0.4 (0.06–3.06) | 0.38 |  |  |
 Yes | 556 (93.3) | 40 (6.7) | 1 |  |  |  |
Gravidity | ||||||
 Primigravida | 219 (90.1) | 24 (9.9) | 3.1 (1.22–7.63) | 0.02 | 3.0 (0.88–10.04) | 0.08 |
 Multigravida | 204 (94.9) | 11 (5.1) | 1.5 (0.544–4.143) | 0.43 | 1.07 (0.30–3.85) | 0.92 |
 Secundigravida | 167 (96.5) | 6 (3.5) | 1 |  |  |  |
Gestation age (weeks) | ||||||
  ≤ 36 | 42 (72.4) | 16 (27.6) | 8.4 (4.14–16.88) | < 0.01 | 1.12 (0.06–0.25) | < 0.01 |
  ≥ 37 | 548 (95.6) | 25 (4.4) | 1 |  |  |  |
IPTp-SP doses taken | ||||||
 0 | 12 (85.7) | 2 (14.3) | 1 |  |  |  |
 1 | 64 (91.4) | 6 (8.6) | 0.56 (0.10–3.31) | 0.51 | 0.25 (0.04–1.56) | 0.13 |
 2 | 155 (91.7) | 14 (8.3) | 0.54 (0.11–2.67) | 0.45 | 0.32 (0.06–1.74) | 0.19 |
  ≥ 3 | 359 (95.0) | 19 (5.0) | 0.32 (0.07–1.52) | 0.15 | 0.17 (0.03–0.88) | 0.04 |
Malaria by MRDT | ||||||
 Positive | 3 (75) | 1 (25) | 4.5 (0.50–48.1) | 0.17 | 11.9 (1.07–132.2) | 0.04 |
 Negative | 587 (93.6) | 40 (6.4) | 1 |  |  |  |
Maternal anemia | ||||||
 Non-anemia (≥11.0 g/dL | 349 (93.3) | 25 (6.7) | 1 |  |  |  |
 Mild anemia (10–10.9 g/dL) | 139 (95.9) | 6 (4.1) | 0.242–1.501 | 0.28 | 1.16 (0.11–12.6) | 0.9 |
 Moderate anemia (7.0–9.9 g/dL) | 94 (91.3) | 9 (8.7) | 0.603–2.960 | 0.48 | 0.51 (0.04–5.78) | 0.58 |
 Severe anemia (< 7.0 g/dL) | 8 (88.9) | 1 (11.1) | 0.21–14.510 | 0.61 | 1.01 (0.10–9.99) | 0.995 |
Foetal anemia | ||||||
 Yes | 34 (91.9) | 3 (8.1) | 0.78 (0.23–2.64) | 0.68 |  |  |
 No | 556 (93.6) | 38 (6.4) | 1 |  |  |  |